期刊文献+

宫颈鳞癌分化程度与^(18)F-脱氧葡萄糖PET/CT显像最大标准摄取值之间的关系 被引量:5

Correlation between degree of pathological differentiation of cervical squamous cell carcinoma and maximal standardized uptake value of ^(18)F-fluorodeoxyglucose PET/CT
下载PDF
导出
摘要 目的:分析宫颈鳞癌分化程度与18F-脱氧葡萄糖(18F-FDG)PET/CT显像定量指标最大标准摄取值(SUVmax)之间的关系。方法:回顾性分析经手术或阴道镜病理证实的28例宫颈鳞癌患者,比较分析宫颈鳞癌病理分化程度及SUVmax,探讨18F-FDG PET/CT定量指标与恶性肿瘤分化程度之间的关系及相关程度。结果:不同分化程度宫颈鳞癌的18F-FDG PET/CT的SUVmax存在显著差异,分化程度与SUVmax呈负相关(r=-0.845,P<0.05)。结论:根据18F-FDG PET/CT显像的SUVmax可初步判断宫颈鳞癌的病理分化程度。 Objective: To investigate the correlation between the degree of pathological differentiation of cervical squamous cell carcinoma and the quantitative indicator—maximal standardized uptake value (SUVmax) of 18F-fluorodeoxyglucose (18F-FDG) PET/CT imaging. Methods: A retrospective analysis was made in 28 cases of cervical squamous cell carcinoma confirmed by operation or pathology. The correlation between quantitative parameters of 18F-FDG PET/CT and malignant degree of cervical cancer was analyzed. Results:There was signiifcant difference between SUVmax and the degree of pathological differentiation of cervical squamous cell carcinoma (r=-0.845, P〈0.05). Conclusion:SUVmax of 18F-FDG PET/CT imaging can preliminarily judge the degree of pathological differentiation of cervical squamous cell carcinoma.
出处 《肿瘤影像学》 2015年第1期13-15,共3页 Oncoradiology
关键词 宫颈癌 正电子发射断层显像术 18F-脱氧葡萄糖 Cervical cancer Positron emission tomography 18F-fluorodeoxyglucose
  • 相关文献

参考文献5

  • 1International Agency for Research on Cancer. GLOBOCAN 2012 [EB/OL]. http://globocan.iarc.fr/ Default.aspx.
  • 2REY-ARES L, CIAPPONI A, PICHON-RIVIERE A. Efficacy and safety of human papilloma virus vaccine in cervical cancer prevention: systematic review and meta- analysis [J]. Arch Argent Pediatr, 2012, 110(6): 483-489.
  • 3刘文欣,陈颖,杨广明.144例宫颈腺癌临床与预后相关因素分析[J].中国肿瘤临床,2011,38(11):664-667. 被引量:14
  • 4辛军,王丹波.PET/CT在妇科恶性肿瘤诊断中的价值[J].中国实用妇科与产科杂志,2010,26(9):720-722. 被引量:11
  • 5KIDD E A, SIEGEL B A, DEHDASHTI F, et al. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival . Cancer, 2007, 110(8): 1738-1744.

二级参考文献26

  • 1李华,章文华,张蓉,吴令英,李晓光,白萍.子宫颈腺癌159例预后影响因素分析[J].中华妇产科杂志,2005,40(4):235-238. 被引量:19
  • 2吴湖炳,王全师,王明芳,王欣璐,郭晓君.呋塞米介入试验在泌尿生殖系统肿瘤^(18)F-FDG PET/CT显像中的应用[J].中华核医学杂志,2005,25(4):206-208. 被引量:23
  • 3魏梅,梁立治,袁颂华,颜笑健,杜佩妍,沈扬.宫颈腺癌105例临床病例分析[J].中国肿瘤临床,2005,32(21):1227-1230. 被引量:14
  • 4绿宝明.子宫颈腺癌86例临床及预后分析[J].南方医科大学学报,2006,26(8):1248-1249. 被引量:2
  • 5Even-Sapir E, Metser U, Flusser G, et al. Assessment of malignant skeletal disease: initial experience with ^18F-fluoride PET/ CT and comparison between ^18F-fluoride PET and ^18F-fluoride PET/CT[ J]. J Nucl Med, 2004,45:272-278.
  • 6Grahek D, Montravers F, Kerrou K, et al. ^18 F-FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management [ J ]. Eur J Nucl Med Mol Imaging,2004,31 (2) : 179-188.
  • 7Arulampalam THA, Costa DC, Loizidou M, et al. The role of positron emission tomography in the management of coloreetal cancer[J]. Br J Surg, 2001,88 : 1-14.
  • 8Havrilesky LI,Wong TZ,Sccord AA,et al. The role of PET scanning in the detection of recurrent cervical cancer [ J ]. Gyneeol Oncol, 2003,90 : 186-! 90.
  • 9Sakurai H, Suzuki Y, Nonaka T, et al. FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy-tumor volume and FDG uptake value [ J ]. Gynecol Oncol ,2006,100:601-607.
  • 10Unger JB, Ivy JJ, Connor P, et al. Detection of recurrent cervical cancer by wholc-body : FDG PET scan in asymptomatic and symptomatic women[ J]. Gynecol Oncol,2004,94:212-216.

共引文献23

同被引文献26

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部